"Helping regenerative medicine innovators secure accelerated
opportunities for patient healing."
Who We Are
Global regenerative medicine team with deep subject matter expertise, FDA insight and Scientific Acumen.
We have our finger directly on the pulse of regulatory reform, and by using a full spectrum approach, we commit to each other, and our biotechnology clients, the skills and up-to-date knowledge needed to optimize their position and preparedness for approval of healing technologies in the regenerative medicine space.
For practitioners, we serve as strategic innovators in patient engagement, shared decision-making methods, precision informed consent practices, lead conversion, and clinical practice compliance with FDA trends, interpretations, and requirements. We help them both leverage their strengths and address the remaining weaknesses that may bring their regenerative medicine pursuits risk or regulatory scrutiny.
"Regenerative Outcomes brings significant value to any regenerative medicine company or clinical practice by helping them navigate the complexities of regenerative medicine regulatory policy and compliance."
~Founder Douglas Oliver, MSW
What We Do
The emergence of regenerative medicine as a new paradigm of healthcare brings a need for rapid, decisive response to change. This is reflected in the way research is conducted, medicine is practiced, drugs are developed, and patients are helped.
Regenerative Outcomes is a distributed group of world class scientists and regulatory experts in regenerative medicine translation from "bench to bedside". We provide biotechnology companies turnkey services to propel their therapeutic products and innovative devices into FDA compliance and accelerated regulatory approval strategies, and support clinical practitioners with compliance assessments and remediation, and compliance services that transform their protocols, public messaging, patient services, and positioning with regulatory authorities.